After surviving cancer,cardiovascular prevention should not be forgotten

Chang HM Okwuosa TM Scarabelli T , et al. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2. J Am Coll Cardiol 2017; 70: 2552–2565.

Darby SC Ewertz M McGale P , et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987–998.

Bradshaw PT Stevens J Khankari N , et al. Cardiovascular disease mortality among breast cancer survivors. Epidemiology 2016; 27: 6–13.

Yandrapalli S Malik AH Pemmasani G , et al. Risk factors and outcomes during a first acute myocardial infarction in breast cancer survivors compared with females without breast cancer. Am J Med. Epub ahead of print 9 November 2019. DOI: 10.1016/j.amjmed.2019.10.018.

Roule V Verdier L Blanchart K , et al. Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention. BMC Cardiovasc Disord 2020; 20: 38.

Barac A Murtagh G Carver JR , et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol 2015; 65: 2739–2746.

Shin S Wook Shin D Young Cho I , et al. Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: a Korean National Health and Nutrition Examination Survey study. Eur J Prev Cardiol. Epub ahead of print 23 February 2020. DOI: 10.1177/2047487320905722.

Daher IN Daigle TR Bhatia N , et al. The prevention of cardiovascular disease in cancer survivors. Tex Heart Inst J 2012; 39: 190–198.

Zamorano JL Lancellotti P Rodriguez Muñoz D , et al. 2016 ESC Position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2768–2801.

Howden EJ Bigaran A Beaudry R , et al. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol 2019; 26: 305–315.

Mulrooney DA Yeazel MW Kawashima T , et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009; 339: b4606.